Field Sales Layoffs?

[Anonymous]

Rumblings at home office about possible buyout and layof of sales division. Another company looking at taro's products but not the sales force. Great, just what we needed.

 

[Anonymous]

which company ? Isn't SUN almost there in buying TARO. their buyout price will not fly...they will have to pay triple the price.

 

[Anonymous]

I have seen this happen before. One salesperson to promote multiple products. They won't need one person to just sell Taro products. Gets rid of the overlapping sales personnel. Looks good on paper, but is almost always poorly implemented.

 

[Anonymous]

I have seen this happen before. One salesperson to promote multiple products. They won't need one person to just sell Taro products. Gets rid of the overlapping sales personnel. Looks good on paper, but is almost always poorly implemented.

Seriuosly how long do you think topicort can keep us going?

 

[Anonymous]

Not much longer, two of your products are about to be sold. You will be asked to sell a pathetic otc competitor and shortly thereafter, as your sales predictably drop, you will be "thinned" to darken the bottom line.

 

[Anonymous]

Jeez, it's no wonder BS wants to abandon this sinking ship...

 

[Anonymous]

Jeez, it's no wonder BS wants to abandon this sinking ship...

Wish I got paid to walk around all day.

 

[Anonymous]

Here we go again- drunken manager at sales meeting ranting about layoffs if sales don't improve. He is always drunk, but not usually ranting about layoffs . Anybody hear anything?

 

[Anonymous]

Here we go again- drunken manager at sales meeting ranting about layoffs if sales don't improve. He is always drunk, but not usually ranting about layoffs . Anybody hear anything?

Yes, heard the same from him. TUSA quietly in talks with Galderma for product purchase without rep transfer to Galderma. New spray leading the discussion.

 

[Anonymous]

Mumbai, March 17:

In its second acquisition in a little over a month, Sun Pharma has acquired URL generic business from Japanese drug-maker Takeda for an undisclosed amount.

Sun’s wholly-owned subsidiary in the US, Caraco Pharmaceutical Laboratories, has entered into a definitive agreement with Takeda Pharmaceuticals USA (a wholly-owned subsidiary of Takeda), to buy the URL Pharma generic business, Sun said.

URL Pharma Inc, formerly a privately held Philadelphia-based pharmaceutical company, had been acquired by Takeda America Holdings in June 2012 for $ 800 million.

In fact, early last month, Sun had entered into an agreement to acquire DUSA, a US-based dermatology company, for about $230 million (over Rs 1,200 crore) in cash.

Sun’s last buy, of Israeli generic drugs-maker Taro, had seen a multi-country battle over three years. A Sun official had said after the DUSA acquisition that it would fund the transaction from its kitty of $1 billion.